AU2001261368A1 - Modulation of gamma-secretase activity - Google Patents

Modulation of gamma-secretase activity

Info

Publication number
AU2001261368A1
AU2001261368A1 AU2001261368A AU6136801A AU2001261368A1 AU 2001261368 A1 AU2001261368 A1 AU 2001261368A1 AU 2001261368 A AU2001261368 A AU 2001261368A AU 6136801 A AU6136801 A AU 6136801A AU 2001261368 A1 AU2001261368 A1 AU 2001261368A1
Authority
AU
Australia
Prior art keywords
app
gamma
secretase
assay
cells expressing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261368A
Other languages
English (en)
Inventor
Barbara Cordell
Jeffrey N Higaki
Mitchell Mutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scios LLC
Original Assignee
Scios LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22754280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001261368(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scios LLC filed Critical Scios LLC
Publication of AU2001261368A1 publication Critical patent/AU2001261368A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001261368A 2000-05-11 2001-05-09 Modulation of gamma-secretase activity Abandoned AU2001261368A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20350600P 2000-05-11 2000-05-11
US60/203,506 2000-05-11
PCT/US2001/015089 WO2001085924A2 (en) 2000-05-11 2001-05-09 MODULATION OF η-SECRETASE ACTIVITY

Publications (1)

Publication Number Publication Date
AU2001261368A1 true AU2001261368A1 (en) 2001-11-20

Family

ID=22754280

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261368A Abandoned AU2001261368A1 (en) 2000-05-11 2001-05-09 Modulation of gamma-secretase activity

Country Status (8)

Country Link
US (2) US6579689B2 (de)
EP (1) EP1305406B2 (de)
JP (1) JP2003532413A (de)
AT (1) ATE339496T1 (de)
AU (1) AU2001261368A1 (de)
DE (1) DE60123074T3 (de)
DK (1) DK1305406T4 (de)
WO (1) WO2001085924A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004505608A (ja) * 2000-04-03 2004-02-26 ブリストル−マイヤーズ　スクイブ　カンパニー 機能的に活性なガンマ−セクレターゼタンパク質複合体の単離およびその活性およびインヒビターの検出法
US20030022251A1 (en) * 2001-07-04 2003-01-30 Boehringer Ingelheim Pharma Kg Gamma-secretase in vitro screening assay
WO2003057165A2 (en) * 2002-01-04 2003-07-17 The Rockefeller University COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
CN1319987C (zh) * 2002-04-24 2007-06-06 森启 γ－分泌酶抑制剂
AU2006203819A1 (en) * 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
EP2461673A4 (de) 2009-08-05 2013-08-07 Intra Cellular Therapies Inc Neue regulatorproteine und hemmer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372888A (en) † 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
CA2191924A1 (en) * 1995-12-05 1997-06-06 Kevin Felsenstein 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of .beta.-amyloid protein production
GB9608657D0 (en) * 1996-04-26 1996-07-03 Smithkline Beecham Plc Novel treatment
WO1998015828A1 (en) 1996-10-07 1998-04-16 Scios Inc. Method to identify direct inhibitors of the beta-amyloid forming enzyme gamma-secretase
US6313268B1 (en) † 1998-10-16 2001-11-06 Vivian Y. H. Hook Secretases related to Alzheimer's dementia
DE19941039A1 (de) * 1999-08-28 2001-03-01 Boehringer Ingelheim Pharma gamma-Sekretase in vitro Testsystem
DE10000161A1 (de) * 2000-01-06 2001-07-19 Boehringer Ingelheim Pharma Verfahren zur Identifikation eines Proteaseinhibitors
JP2004505608A (ja) * 2000-04-03 2004-02-26 ブリストル−マイヤーズ　スクイブ　カンパニー 機能的に活性なガンマ−セクレターゼタンパク質複合体の単離およびその活性およびインヒビターの検出法

Also Published As

Publication number Publication date
DK1305406T4 (en) 2015-02-02
WO2001085924A3 (en) 2003-02-27
WO2001085924A2 (en) 2001-11-15
EP1305406B2 (de) 2014-11-12
DE60123074T2 (de) 2007-03-01
US20010055782A1 (en) 2001-12-27
DK1305406T3 (da) 2007-01-08
JP2003532413A (ja) 2003-11-05
US20030211559A1 (en) 2003-11-13
EP1305406B1 (de) 2006-09-13
EP1305406A2 (de) 2003-05-02
US6579689B2 (en) 2003-06-17
DE60123074D1 (de) 2006-10-26
ATE339496T1 (de) 2006-10-15
DE60123074T3 (de) 2015-01-29

Similar Documents

Publication Publication Date Title
DK1210411T3 (da) Sammensætninger og fremgangsmåder til forbedret celledyrkning
ATE450635T1 (de) Elektrochemische herstellung von peroxo- dischwefelsäure unter einsatz von diamantbeschichteten elektroden
WO2001016285A3 (en) Novel proteases and variants thereof
WO2003104418A3 (en) RECONSTITUTED POLYPEPTIDES
BR0009362A (pt) Variante de uma alfa-amilase semelhante atermamyl precursora, construção de dna, vetorde expressão recombinante, célula, composição,processo para gerar uma variante de umaalfa-amilase semelhante a termamyl precursora,e, uso de uma variante de alfa-amilase
Fox et al. Identification of potential activators of proteinase‐activated receptor‐2 1
IL150168A0 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
NZ595497A (en) Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
MXPA02012324A (es) Metodos y composiciones para la sacarificacion y fermentacion simultaneas.
MX2010001481A (es) Proteasas fungales acidas.
EP1644514A4 (de) Temperaturstabile amylase-polypeptide, für diese polypeptide codierende nukleinsäuren und verwendungen davon
BR0114373A (pt) Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante
EP1939278A4 (de) Verfahren zur herstellung einer t-zellpopulation
MXPA03005548A (es) Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
WO2002072851A3 (en) Lentiviral packaging constructs
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
AU2001261368A1 (en) Modulation of gamma-secretase activity
WO2004011637A3 (en) Modified adamts4 molecules and method of use thereof
AU2099301A (en) Method for obtaining proteins having improved functional characteristics
DE69636922D1 (de) Verbesserte neurospora-wirtszellen zur herstellung rekombinanter proteine und methoden zu deren herstellung
WO2003021265A8 (en) Genetic construct intracellular monitoring system
WO2003012089A3 (en) Crystal structure of beta-site app cleaving enzyme (bace) and use thereof
WO2004024870A3 (en) Construction of bacillus licheniformis t1 strain and fermentation production of crude enzyme extract therefrom
GB9720693D0 (en) Assay
WO1999037758A3 (en) Expression of proteolytically-sensitive peptides